Loading...
XKRX
228670
Market cap49mUSD
Jul 10, Last price  
4,750.00KRW
1D
5.09%
1Q
-34.48%
IPO
-67.80%
Name

Ray Co Ltd

Chart & Performance

D1W1MN
XKRX:228670 chart
P/E
23.62
P/S
0.67
EPS
201.12
Div Yield, %
Shrs. gr., 5y
3.23%
Rev. gr., 5y
15.04%
Revenues
111.23b
+39.31%
32,929,247,70051,533,644,72373,108,726,00055,204,787,00090,336,177,000128,997,854,000145,881,865,00079,842,594,000111,230,411,000
Net income
3.14b
P
1,154,195,6495,251,390,26011,555,269,0007,903,630,000-12,765,0007,956,938,000-2,146,320,000-60,426,549,0003,137,937,000
CFO
12.85b
+6,184.82%
1,101,372,2314,297,843,8456,039,622,0002,903,332,00011,172,369,000-8,231,215,000-22,790,636,000204,512,00012,853,215,666

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

RAY Co., Ltd. specializes in delivering x-ray diagnostic tools for the dental sector. Their comprehensive product lineup features the RAYSACN Series, RAYios, RAYFace, RAYDENT Microscan, and the RIO Series, in addition to RAYDENT designer and tray, RAYSmiler, RAYDENT Studio, and the RAYDENT Mill 4X and 5X. They also supply related consumables. Founded in 2004, the company's main operations are based in Seongnam-si, South Korea.
IPO date
Aug 08, 2019
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT